MENU
+Compare
IRMD
Stock ticker: NASDAQ
AS OF
Dec 18, 04:12 PM (EDT)
Price
$53.01
Change
+$0.01 (+0.02%)
Capitalization
557.04M

IRMD iRadimed Corp Forecast, Technical & Fundamental Analysis

a provider of non-magnetic intravenous infusion pump systems

IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for IRMD with price predictions
Dec 17, 2024

Momentum Indicator for IRMD turns negative, indicating new downward trend

IRMD saw its Momentum Indicator move below the 0 level on December 13, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 116 similar instances where the indicator turned negative. In of the 116 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for IRMD moved out of overbought territory on November 12, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for IRMD turned negative on December 13, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 57 similar instances when the indicator turned negative. In of the 57 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.622) is normal, around the industry mean (23.300). P/E Ratio (31.844) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.004) settles around the average of (0.018) among similar stocks. P/S Ratio (8.340) is also within normal values, averaging (43.338).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
IRMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IRMD is expected to report earnings to fall 5.81% to 40 cents per share on February 06

iRadimed Corp IRMD Stock Earnings Reports
Q4'24
Est.
$0.41
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.03
Q4'23
Beat
by $0.01
The last earnings report on October 31 showed earnings per share of 43 cents, beating the estimate of 38 cents. With 13.49K shares outstanding, the current market capitalization sits at 557.04M.
A.I.Advisor
published Dividends

IRMD paid dividends on November 25, 2024

iRadimed Corp IRMD Stock Dividends
А dividend of $0.15 per share was paid with a record date of November 25, 2024, and an ex-dividend date of November 15, 2024. Read more...
A.I. Advisor
published General Information

General Information

a provider of non-magnetic intravenous infusion pump systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1025 Willa Springs Drive
Phone
+1 407 677-8022
Employees
148
Web
https://www.iradimed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIGYX11.430.09
+0.79%
Loomis Sayles International Growth Y
AEDMX11.60-0.03
-0.27%
American Century Emerging Markets R6
POIRX16.02-0.05
-0.31%
Polen International Growth Investor
JRSDX11.91-0.04
-0.33%
JH Adaptive Risk Mgd U.S. Eq D
VHGEX38.40-0.14
-0.36%
Vanguard Global Equity Inv

IRMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with LUNG. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRMD
1D Price
Change %
IRMD100%
-0.34%
LUNG - IRMD
42%
Loosely correlated
-1.13%
HBIO - IRMD
39%
Loosely correlated
+1.40%
CRL - IRMD
39%
Loosely correlated
-0.39%
BLFS - IRMD
38%
Loosely correlated
-1.83%
GKOS - IRMD
37%
Loosely correlated
+1.54%
More